This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arikan, S.
Right arrow Articles by Rex, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arikan, S.
Right arrow Articles by Rex, J. H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2001, p. 327-330, Vol. 45, No. 1
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.1.327-330.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates

Sevtap Arikan,* Mario Lozano-Chiu, Victor Paetznick, and John H. Rex

Division of Infectious Diseases, Department of Internal Medicine, Center for the Study of Emerging and Reemerging Pathogens, University of Texas Medical School, Houston, Texas 77030

Received 5 June 2000/Returned for modification 11 July 2000/Accepted 18 October 2000

We investigated the relevance of prominent reduction in turbidity macroscopically (MIC) and formation of aberrant hyphal tips microscopically (minimum effective concentration; MEC) in measuring the in vitro activity of caspofungin against Aspergillus and Fusarium. Caspofungin generated low MICs and MECs against Aspergillus, but not for Fusarium. While MICs increased inconsistently when the incubation time was prolonged, MEC appeared as a stable and potentially relevant endpoint in testing in vitro caspofungin activity.

* Corresponding author. Present address: Hacettepe University Medical School, Department of Microbiology and Clinical Microbiology, 06100 Ankara, Turkey. Phone: 90-312-3051562. Fax: 90-312-3115250. E-mail: sarikan{at}metu.edu.tr.

Antimicrobial Agents and Chemotherapy, January 2001, p. 327-330, Vol. 45, No. 1
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.1.327-330.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Lass-Florl, C., Mayr, A., Perkhofer, S., Hinterberger, G., Hausdorfer, J., Speth, C., Fille, M. (2008). Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob. Agents Chemother. 52: 3637-3641 [Abstract] [Full Text]  
  • Castelli, M. V., Alastruey-Izquierdo, A., Cuesta, I., Monzon, A., Mellado, E., Rodriguez-Tudela, J. L., Cuenca-Estrella, M. (2008). Susceptibility Testing and Molecular Classification of Paecilomyces spp.. Antimicrob. Agents Chemother. 52: 2926-2928 [Abstract] [Full Text]  
  • Perkhofer, S., Jost, D., Dierich, M. P., Lass-Florl, C. (2008). Susceptibility Testing of Anidulafungin and Voriconazole Alone and in Combination against Conidia and Hyphae of Aspergillus spp. under Hypoxic Conditions. Antimicrob. Agents Chemother. 52: 1873-1875 [Abstract] [Full Text]  
  • Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., Walsh, T. J. (2008). Comparative In Vitro Pharmacodynamics of Caspofungin, Micafungin, and Anidulafungin against Germinated and Nongerminated Aspergillus Conidia. Antimicrob. Agents Chemother. 52: 321-328 [Abstract] [Full Text]  
  • Khan, Z. U., Ahmad, S., Theyyathel, A. M. (2008). Diagnostic value of DNA and (1->3)- -D-glucan detection in serum and bronchoalveolar lavage of mice experimentally infected with Fusarium oxysporum. J Med Microbiol 57: 36-42 [Abstract] [Full Text]  
  • Johnson, E. M. (2008). Issues in antifungal susceptibility testing. J Antimicrob Chemother 61: i13-i18 [Abstract] [Full Text]  
  • Plummer, R., Bodkin, J., Power, D., Pantarat, N., Bubb, W. A., Kuchel, P. W., Sorrell, T. C. (2007). Effect of Caspofungin on Metabolite Profiles of Aspergillus Species Determined by Nuclear Magnetic Resonance Spectroscopy. Antimicrob. Agents Chemother. 51: 4077-4084 [Abstract] [Full Text]  
  • Almyroudis, N. G., Sutton, D. A., Fothergill, A. W., Rinaldi, M. G., Kusne, S. (2007). In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents. Antimicrob. Agents Chemother. 51: 2587-2590 [Abstract] [Full Text]  
  • Lalitha, P., Shapiro, B. L., Srinivasan, M., Prajna, N. V., Acharya, N. R., Fothergill, A. W., Ruiz, J., Chidambaram, J. D., Maxey, K. J., Hong, K. C., McLeod, S. D., Lietman, T. M. (2007). Antimicrobial Susceptibility of Fusarium, Aspergillus, and Other Filamentous Fungi Isolated From Keratitis. Arch Ophthalmol 125: 789-793 [Abstract] [Full Text]  
  • Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., Walsh, T. J. (2007). Concentration-Dependent Effects of Caspofungin on the Metabolic Activity of Aspergillus Species. Antimicrob. Agents Chemother. 51: 881-887 [Abstract] [Full Text]  
  • Bowman, J. C., Abruzzo, G. K., Flattery, A. M., Gill, C. J., Hickey, E. J., Hsu, M. J., Nielsen Kahn, J., Liberator, P. A., Misura, A. S., Pelak, B. A., Wang, T. C., Douglas, C. M. (2006). Efficacy of Caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulans. Antimicrob. Agents Chemother. 50: 4202-4205 [Abstract] [Full Text]  
  • Cacciapuoti, A., Halpern, J., Mendrick, C., Norris, C., Patel, R., Loebenberg, D. (2006). Interaction between Posaconazole and Caspofungin in Concomitant Treatment of Mice with Systemic Aspergillus Infection.. Antimicrob. Agents Chemother. 50: 2587-2590 [Abstract] [Full Text]  
  • van Vianen, W., de Marie, S., ten Kate, M. T., Mathot, R. A. A., Bakker-Woudenberg, I. A. J. M. (2006). Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis. J Antimicrob Chemother 57: 732-740 [Abstract] [Full Text]  
  • Barchiesi, F., Spreghini, E., Santinelli, A., Fothergill, A. W., Fallani, S., Manso, E., Pisa, E., Giannini, D., Novelli, A., Cassetta, M. I., Mazzei, T., Rinaldi, M. G., Scalise, G. (2005). Efficacy of Caspofungin against Aspergillus terreus. Antimicrob. Agents Chemother. 49: 5133-5135 [Abstract] [Full Text]  
  • MacCallum, D. M., Whyte, J. A., Odds, F. C. (2005). Efficacy of Caspofungin and Voriconazole Combinations in Experimental Aspergillosis. Antimicrob. Agents Chemother. 49: 3697-3701 [Abstract] [Full Text]  
  • Pavie, J., Lacroix, C., Hermoso, D. G., Robin, M., Ferry, C., Bergeron, A., Feuilhade, M., Dromer, F., Gluckman, E., Molina, J.-M., Ribaud, P. (2005). Breakthrough Disseminated Aspergillus ustus Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole or Caspofungin Prophylaxis. J. Clin. Microbiol. 43: 4902-4904 [Abstract] [Full Text]  
  • Guinea, J., Pelaez, T., Alcala, L., Ruiz-Serrano, M. J., Bouza, E. (2005). Antifungal Susceptibility of 596 Aspergillus fumigatus Strains Isolated from Outdoor Air, Hospital Air, and Clinical Samples: Analysis by Site of Isolation. Antimicrob. Agents Chemother. 49: 3495-3497 [Abstract] [Full Text]  
  • Yustes, C., Guarro, J. (2005). In Vitro Synergistic Interaction between Amphotericin B and Micafungin against Scedosporium spp.. Antimicrob. Agents Chemother. 49: 3498-3500 [Abstract] [Full Text]  
  • Fernandez-Torres, B., Inza, I., Guarro, J. (2005). Evaluation of Disk Diffusion Method for Determining Eberconazole Susceptibility of Dermatophytes and Influence of Culture Medium. Antimicrob. Agents Chemother. 49: 2116-2118 [Abstract] [Full Text]  
  • De Logu, A., Saddi, M., Cardia, M. C., Borgna, R., Sanna, C., Saddi, B., Maccioni, E. (2005). In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans. J Antimicrob Chemother 55: 692-698 [Abstract] [Full Text]  
  • Singh, N., Paterson, D. L. (2005). Aspergillus Infections in Transplant Recipients. Clin. Microbiol. Rev. 18: 44-69 [Abstract] [Full Text]  
  • Steinbach, W. J., Singh, N., Miller, J. L., Benjamin, D. K. Jr., Schell, W. A., Heitman, J., Perfect, J. R. (2004). In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus Isolates from Transplant and Nontransplant Patients. Antimicrob. Agents Chemother. 48: 4922-4925 [Abstract] [Full Text]  
  • Imai, J. K., Singh, G., Clemons, K. V., Stevens, D. A. (2004). Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis. Antimicrob. Agents Chemother. 48: 4063-4066 [Abstract] [Full Text]  
  • Steinbach, W. J., Perfect, J. R., Schell, W. A., Walsh, T. J., Benjamin, D. K. Jr. (2004). In Vitro Analyses, Animal Models, and 60 Clinical Cases of Invasive Aspergillus terreus Infection. Antimicrob. Agents Chemother. 48: 3217-3225 [Full Text]  
  • Odds, F. C., Motyl, M., Andrade, R., Bille, J., Canton, E., Cuenca-Estrella, M., Davidson, A., Durussel, C., Ellis, D., Foraker, E., Fothergill, A. W., Ghannoum, M. A., Giacobbe, R. A., Gobernado, M., Handke, R., Laverdiere, M., Lee-Yang, W., Merz, W. G., Ostrosky-Zeichner, L., Peman, J., Perea, S., Perfect, J. R., Pfaller, M. A., Proia, L., Rex, J. H., Rinaldi, M. G., Rodriguez-Tudela, J.-L., Schell, W. A., Shields, C., Sutton, D. A., Verweij, P. E., Warnock, D. W. (2004). Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species. J. Clin. Microbiol. 42: 3475-3482 [Abstract] [Full Text]  
  • Steinbach, W. J., Schell, W. A., Blankenship, J. R., Onyewu, C., Heitman, J., Perfect, J. R. (2004). In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus. Antimicrob. Agents Chemother. 48: 1664-1669 [Abstract] [Full Text]  
  • Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., Rex, J. H. (2004). Combination Antifungal Therapy. Antimicrob. Agents Chemother. 48: 693-715 [Full Text]  
  • Dannaoui, E., Lortholary, O., Dromer, F. (2004). In Vitro Evaluation of Double and Triple Combinations of Antifungal Drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob. Agents Chemother. 48: 970-978 [Abstract] [Full Text]  
  • Imhof, A., Balajee, S. A., Marr, K. A. (2003). New Methods To Assess Susceptibilities of Aspergillus Isolates to Caspofungin. J. Clin. Microbiol. 41: 5683-5688 [Abstract] [Full Text]  
  • Barron, M. A., Sutton, D. A., Veve, R., Guarro, J., Rinaldi, M., Thompson, E., Cagnoni, P. J., Moultney, K., Madinger, N. E. (2003). Invasive Mycotic Infections Caused by Chaetomium perlucidum, a New Agent of Cerebral Phaeohyphomycosis. J. Clin. Microbiol. 41: 5302-5307 [Abstract] [Full Text]  
  • Serena, C., Ortoneda, M., Capilla, J., Pastor, F. J., Sutton, D. A., Rinaldi, M. G., Guarro, J. (2003). In Vitro Activities of New Antifungal Agents against Chaetomium spp. and Inoculum Standardization. Antimicrob. Agents Chemother. 47: 3161-3164 [Abstract] [Full Text]  
  • Arikan, S., Yurdakul, P., Hascelik, G. (2003). Comparison of Two Methods and Three End Points in Determination of In Vitro Activity of Micafungin against Aspergillus spp.. Antimicrob. Agents Chemother. 47: 2640-2643 [Abstract] [Full Text]  
  • Diekema, D. J., Messer, S. A., Hollis, R. J., Jones, R. N., Pfaller, M. A. (2003). Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi. J. Clin. Microbiol. 41: 3623-3626 [Abstract] [Full Text]  
  • Bartizal, C., Odds, F. C. (2003). Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatus. Antimicrob. Agents Chemother. 47: 2100-2107 [Abstract] [Full Text]  
  • Van Epps, H. L., Feldmesser, M., Pamer, E. G. (2003). Voriconazole Inhibits Fungal Growth without Impairing Antigen Presentation or T-Cell Activation. Antimicrob. Agents Chemother. 47: 1818-1823 [Abstract] [Full Text]  
  • Shalit, I., Shadkchan, Y., Samra, Z., Osherov, N. (2003). In Vitro Synergy of Caspofungin and Itraconazole against Aspergillus spp.: MIC versus Minimal Effective Concentration End Points. Antimicrob. Agents Chemother. 47: 1416-1418 [Abstract] [Full Text]  
  • Letscher-Bru, V., Herbrecht, R. (2003). Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother 51: 513-521 [Abstract] [Full Text]  
  • Espinel-Ingroff, A. (2003). Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991). J. Clin. Microbiol. 41: 403-409 [Abstract] [Full Text]  
  • Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R., Lopez-Ribot, J. L. (2002). In Vitro Activity of Caspofungin against Candida albicans Biofilms. Antimicrob. Agents Chemother. 46: 3591-3596 [Abstract] [Full Text]  
  • Perea, S., Gonzalez, G., Fothergill, A. W., Kirkpatrick, W. R., Rinaldi, M. G., Patterson, T. F. (2002). In Vitro Interaction of Caspofungin Acetate with Voriconazole against Clinical Isolates of Aspergillus spp.. Antimicrob. Agents Chemother. 46: 3039-3041 [Abstract] [Full Text]  
  • Arikan, S., Paetznick, V., Rex, J. H. (2002). Comparative Evaluation of Disk Diffusion with Microdilution Assay in Susceptibility Testing of Caspofungin against Aspergillus and Fusarium Isolates. Antimicrob. Agents Chemother. 46: 3084-3087 [Abstract] [Full Text]  
  • Kirkpatrick, W. R., Perea, S., Coco, B. J., Patterson, T. F. (2002). Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis. Antimicrob. Agents Chemother. 46: 2564-2568 [Abstract] [Full Text]  
  • Ortoneda, M., Capilla, J., Pastor, F. J., Pujol, I., Guarro, J. (2002). Efficacy of Liposomal Amphotericin B in Treatment of Systemic Murine Fusariosis. Antimicrob. Agents Chemother. 46: 2273-2275 [Abstract] [Full Text]  
  • Petraitiene, R., Petraitis, V., Groll, A. H., Sein, T., Schaufele, R. L., Francesconi, A., Bacher, J., Avila, N. A., Walsh, T. J. (2002). Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia. Antimicrob. Agents Chemother. 46: 12-23 [Abstract] [Full Text]  
  • Arikan, S., Lozano-Chiu, M., Paetznick, V., Rex, J. H. (2002). In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp.. Antimicrob. Agents Chemother. 46: 245-247 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»